This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Khairy P et al. (2003) Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 139: 753–760
Mas JL et al. for the Patent Foramen Ovale and Atrial Septal Aneurysm Study Group (2001) Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345: 1740–1746
Meissner I et al. (1999) Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke prevention: assessment of risk in a community. Mayo Clin Proc 74: 862–869
Acknowledgements
The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
LA Latson has received research support from W.L. Gore & Associates, NMT Medical, and AGA Medical. He has also acted as Consultant for W.L. Gore & Associates.
Rights and permissions
About this article
Cite this article
Latson, L. Percutaneous closure of patent foramen ovale: have we achieved the 'utopian' ideal?. Nat Rev Cardiol 5, 442–443 (2008). https://doi.org/10.1038/ncpcardio1270
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio1270